A detailed history of Ken Fisher (Fisher Asset Management, LLC) transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, Fisher Asset Management, LLC holds 184,692 shares of CRL stock, worth $34.7 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
184,692
Previous 183,106 0.87%
Holding current value
$34.7 Million
Previous $37.8 Million 3.82%
% of portfolio
0.01%
Previous 0.02%

Shares

33 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$187.96 - $245.29 $298,104 - $389,029
1,586 Added 0.87%
184,692 $36.4 Million
Q2 2024

Aug 14, 2024

SELL
$206.39 - $268.73 $319,698 - $416,262
-1,549 Reduced 0.84%
183,106 $37.8 Million
Q1 2024

May 09, 2024

SELL
$203.52 - $273.43 $360,433 - $484,244
-1,771 Reduced 0.95%
184,655 $50 Million
Q4 2023

Mar 05, 2024

SELL
$164.52 - $238.84 $329 - $477
-2 Reduced -0.0%
186,426 $44.1 Million
Q4 2023

Feb 06, 2024

SELL
$164.52 - $238.84 $373,789 - $542,644
-2,272 Reduced 1.2%
186,428 $44.1 Million
Q3 2023

Nov 13, 2023

SELL
$194.44 - $217.61 $2.66 Million - $2.97 Million
-13,667 Reduced 6.75%
188,700 $37 Million
Q2 2023

Dec 12, 2023

BUY
$183.71 - $210.25 $2.51 Million - $2.87 Million
13,667 Added 7.24%
202,367 $42.5 Million
Q2 2023

Aug 08, 2023

SELL
$183.71 - $210.25 $7.3 Million - $8.35 Million
-39,723 Reduced 16.41%
202,367 $42.5 Million
Q1 2023

Dec 12, 2023

BUY
$191.89 - $259.92 $5.28 Million - $7.16 Million
27,535 Added 14.59%
216,235 $43.6 Million
Q1 2023

May 01, 2023

SELL
$191.89 - $259.92 $1.74 Million - $2.35 Million
-9,050 Reduced 3.6%
242,090 $48.9 Million
Q4 2022

Feb 03, 2023

BUY
$197.11 - $250.07 $2.05 Million - $2.6 Million
10,381 Added 4.31%
251,140 $54.7 Million
Q3 2022

Nov 08, 2022

SELL
$182.44 - $250.54 $2.24 Million - $3.07 Million
-12,266 Reduced 4.85%
240,759 $47.4 Million
Q2 2022

Aug 09, 2022

BUY
$204.13 - $302.4 $945,326 - $1.4 Million
4,631 Added 1.86%
253,025 $54.1 Million
Q1 2022

May 05, 2022

SELL
$255.51 - $362.11 $835,006 - $1.18 Million
-3,268 Reduced 1.3%
248,394 $70.5 Million
Q4 2021

Feb 02, 2022

BUY
$351.38 - $448.68 $2.99 Million - $3.82 Million
8,521 Added 3.5%
251,662 $94.8 Million
Q3 2021

Oct 26, 2021

BUY
$372.64 - $458.3 $2.95 Million - $3.62 Million
7,909 Added 3.36%
243,141 $100 Million
Q2 2021

Jul 27, 2021

SELL
$294.17 - $371.65 $851,916 - $1.08 Million
-2,896 Reduced 1.22%
235,232 $87 Million
Q1 2021

Apr 27, 2021

SELL
$249.67 - $299.48 $851,624 - $1.02 Million
-3,411 Reduced 1.41%
238,128 $69 Million
Q4 2020

Jan 29, 2021

SELL
$222.0 - $252.62 $1.91 Million - $2.17 Million
-8,586 Reduced 3.43%
241,539 $60.4 Million
Q3 2020

Nov 10, 2020

SELL
$175.56 - $226.45 $3.77 Million - $4.86 Million
-21,479 Reduced 7.91%
250,125 $56.6 Million
Q2 2020

Aug 07, 2020

SELL
$118.84 - $189.72 $2.63 Million - $4.19 Million
-22,107 Reduced 7.53%
271,604 $47.4 Million
Q1 2020

Apr 28, 2020

SELL
$98.9 - $178.34 $5.33 Million - $9.6 Million
-53,851 Reduced 15.49%
293,711 $37.1 Million
Q4 2019

Feb 12, 2020

SELL
$126.05 - $152.76 $11.4 Million - $13.9 Million
-90,809 Reduced 20.72%
347,562 $53.1 Million
Q3 2019

Oct 29, 2019

SELL
$125.07 - $143.67 $4.12 Million - $4.74 Million
-32,970 Reduced 6.99%
438,371 $58 Million
Q2 2019

Jul 30, 2019

BUY
$123.4 - $148.55 $3.7 Million - $4.45 Million
29,980 Added 6.79%
471,341 $66.9 Million
Q1 2019

Apr 22, 2019

BUY
$104.82 - $146.73 $596,425 - $834,893
5,690 Added 1.31%
441,361 $64.1 Million
Q4 2018

Jan 25, 2019

BUY
$105.09 - $137.23 $5.93 Million - $7.74 Million
56,394 Added 14.87%
435,671 $49.3 Million
Q3 2018

Oct 24, 2018

BUY
$112.11 - $134.54 $1.63 Million - $1.96 Million
14,538 Added 3.99%
379,277 $51 Million
Q2 2018

Jul 09, 2018

SELL
$102.37 - $117.25 $1.42 Million - $1.63 Million
-13,881 Reduced 3.67%
364,739 $40.9 Million
Q1 2018

May 11, 2018

SELL
$98.19 - $115.2 $22.2 Million - $26 Million
-225,610 Reduced 37.34%
378,620 $40.4 Million
Q1 2018

Apr 19, 2018

BUY
$98.19 - $115.2 $16.5 Million - $19.4 Million
168,202 Added 38.58%
604,230 $64.5 Million
Q4 2017

Jan 24, 2018

SELL
$100.43 - $118.09 $1.62 Million - $1.9 Million
-16,128 Reduced 3.57%
436,028 $47.7 Million
Q3 2017

Oct 17, 2017

BUY
$96.72 - $109.26 $43.7 Million - $49.4 Million
452,156
452,156 $48.8 Million

Others Institutions Holding CRL

About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.


  • Ticker CRL
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 50,863,300
  • Market Cap $9.56B
  • Description
  • Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...
More about CRL
Track Ken Fisher's Portfolio

Track Ken Fisher Portfolio

Follow Ken Fisher (Fisher Asset Management, LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fisher Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fisher Asset Management, LLC and Ken Fisher with notifications on news.